NORA THERAPEUTICS, INC.

Profile

Company Names

NORA THERAPEUTICS, INC.

Addresses

530 LYTTON AVENUE, 2ND FLOOR, PALO ALTO, CA 94301

9871 SHERWOOD FARM RD., OWINGS MILLS, MD 21117

Phone Numbers

1-650-479-5331
(443) 378-7236

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2007

State Incorporated:

DE

Total Amount Raised:

$36,812,000.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2015-09-29 
$1,000,000.00 
$3,000,000.00 
$2,000,000.00 
Debt 
3
2014-04-11 
$18,000,000.00 
$18,000,000.00 
$0.00 
Equity 
2
2010-09-08 
$14,880,000.00 
$32,554,999.00 
$17,674,999.00 
Equity 
1
2009-03-31 
$2,932,000.00 
$25,137,000.00 
$22,205,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DARRYL 
L. 
CARTER 
EXECUTIVE OFFICER
NORA THERAPEUTICS, INC.
ALAN 
 
COLOWICK 
EXECUTIVE OFFICER, DIRECTOR
NORA THERAPEUTICS, INC.   |  PRINCIPIA BIOPHARMA INC.   |  VELOSBIO INC.   |  INCARDA THERAPEUTICS, INC.   |  SOLVE THERAPEUTICS, INC.   |  RECODE THERAPEUTICS, INC.   |  ANUMANA, INC.   |  HARPOON THERAPEUTICS, INC.   |  ALUMIS INC.
ANUPAM 
 
DALAL 
DIRECTOR
AKEBIA THERAPEUTICS, INC.   |  AERPIO THERAPEUTICS, INC.   |  NORA THERAPEUTICS, INC.   |  AERPIO PHARMACEUTICALS, INC.   |  ACUTA OPPORTUNITY FUND, LP   |  ACUTA CAPITAL FUND, LP   |  ACUTA OPPORTUNITY OFFSHORE FUND, LTD.   |  ACUTA CAPITAL OFFSHORE FUND, LTD.   |  AADI BIOSCIENCE, INC.
DENNIS 
 
FENTON 
DIRECTOR
KYTHERA BIOPHARMACEUTICALS INC   |  NAPO PHARMACEUTICALS INC   |  GENELUX CORP   |  NORA THERAPEUTICS, INC.   |  SIENNA BIOPHARMACEUTICALS, INC.   |  MODERN MEADOW, INC.   |  PBS BIOTECH, INC.
BRYANT 
E. 
FONG 
DIRECTOR
NORA THERAPEUTICS, INC.   |  FERROKIN BIOSCIENCES INC   |  ADMA BIOLOGICS, INC.
DONALD 
 
HAYDEN, JR. 
DIRECTOR
TRANSAVE INC   |  INSMED INC   |  NORA THERAPEUTICS, INC.   |  WINDMIL THERAPEUTICS, INC.
DONALD 
J. 
HAYDEN, JR. 
DIRECTOR
NORA THERAPEUTICS, INC.   |  AMICUS THERAPEUTICS INC   |  REGENXBIO INC.   |  DIMENSION THERAPEUTICS, INC.   |  WINDMIL THERAPEUTICS, INC.
CHRISTOPHER 
B. 
MCCLAIN 
EXECUTIVE OFFICER
NORA THERAPEUTICS, INC.
JULIE 
 
MCHUGH 
EXECUTIVE OFFICER, DIRECTOR
NORA THERAPEUTICS, INC.
DAVID 
 
SCHNELL 
DIRECTOR
GLOUCESTER PHARMACEUTICALS INC   |  LUX BIOSCIENCES INC   |  NORA THERAPEUTICS, INC.   |  TRUBION PHARMACEUTICALS, INC   |  NGM BIOPHARMACEUTICALS INC   |  KYTHERA BIOPHARMACEUTICALS INC   |  SATORI PHARMACEUTICALS INC   |  ALVINE PHARMACEUTICALS INC   |  AJAX THERAPEUTICS, INC.
JEFFREY 
K 
TONG 
EXECUTIVE OFFICER, DIRECTOR
NORA THERAPEUTICS, INC.
JEFFREY 
K. 
TONG 
EXECUTIVE OFFICER, DIRECTOR
NORA THERAPEUTICS, INC.
JOSEPH 
L. 
TURNER, JR. 
DIRECTOR
NORA THERAPEUTICS, INC.
MARTIN 
 
VOGELBAUM 
DIRECTOR
GLOUCESTER PHARMACEUTICALS INC   |  MERSANA THERAPEUTICS INC   |  INOTEK PHARMACEUTICALS CORP   |  CARA THERAPEUTICS INC   |  NORA THERAPEUTICS, INC.   |  SARCODE BIOSCIENCE INC.   |  CARA THERAPEUTICS, INC.   |  INNING ONE VENTURES, L.P.   |  AJAX THERAPEUTICS, INC.   |  INNING ONE VENTURES II, L.P.
CHEN 
 
YU 
DIRECTOR
SAGENT HOLDING CO.   |  NORA THERAPEUTICS, INC.   |  NEXCIDA THERAPEUTICS, INC.   |  OUTPOST MEDICINE, LLC   |  KALA PHARMACEUTICALS, INC.   |  SENTREHEART INC   |  VIVO CAPITAL FUND IX, L.P.   |  TCG CROSSOVER FUND I, L.P.   |  ARBOR BIOTECHNOLOGIES, INC.   |  ADARX PHARMACEUTICALS, INC.   |  LB PHARMACEUTICALS INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2015-10-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2015-09-29 
2014-04-23
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-04-11 
2010-09-23
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2010-09-08 
2010-06-02
D/A
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2009-03-31 
2009-04-13
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2009-03-31 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#